Literature DB >> 15084750

Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.

Ellen A A Nollen1, Susana M Garcia, Gijs van Haaften, Soojin Kim, Alejandro Chavez, Richard I Morimoto, Ronald H A Plasterk.   

Abstract

Protein misfolding and the formation of aggregates are increasingly recognized components of the pathology of human genetic disease and hallmarks of many neurodegenerative disorders. As exemplified by polyglutamine diseases, the propensity for protein misfolding is associated with the length of polyglutamine expansions and age-dependent changes in protein-folding homeostasis, suggesting a critical role for a protein homeostatic buffer. To identify the complement of protein factors that protects cells against the formation of protein aggregates, we tested transgenic Caenorhabditis elegans strains expressing polyglutamine expansion yellow fluorescent protein fusion proteins at the threshold length associated with the age-dependent appearance of protein aggregation. We used genome-wide RNA interference to identify genes that, when suppressed, resulted in the premature appearance of protein aggregates. Our screen identified 186 genes corresponding to five principal classes of polyglutamine regulators: genes involved in RNA metabolism, protein synthesis, protein folding, and protein degradation; and those involved in protein trafficking. We propose that each of these classes represents a molecular machine collectively comprising the protein homeostatic buffer that responds to the expression of damaged proteins to prevent their misfolding and aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084750      PMCID: PMC404057          DOI: 10.1073/pnas.0307697101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes.

Authors:  N Tavernarakis; S L Wang; M Dorovkov; A Ryazanov; M Driscoll
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.

Authors:  E Cuppen; M van Ham; D G Wansink; A de Leeuw; B Wieringa; W Hendriks
Journal:  Eur J Cell Biol       Date:  2000-04       Impact factor: 4.492

3.  Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans.

Authors:  T Oeda; S Shimohama; N Kitagawa; R Kohno; T Imura; H Shibasaki; N Ishii
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

Review 4.  Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease.

Authors:  J F Gusella; M E MacDonald
Journal:  Nat Rev Neurosci       Date:  2000-11       Impact factor: 34.870

5.  Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans.

Authors:  L Timmons; D L Court; A Fire
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

6.  Genetic suppression of polyglutamine toxicity in Drosophila.

Authors:  P Kazemi-Esfarjani; S Benzer
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

7.  Identification of genes that modify ataxin-1-induced neurodegeneration.

Authors:  P Fernandez-Funez; M L Nino-Rosales; B de Gouyon; W C She; J M Luchak; P Martinez; E Turiegano; J Benito; M Capovilla; P J Skinner; A McCall; I Canal; H T Orr; H Y Zoghbi; J Botas
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 8.  Review: cellular substrates of the eukaryotic chaperonin TRiC/CCT.

Authors:  A Y Dunn; M W Melville; J Frydman
Journal:  J Struct Biol       Date:  2001-08       Impact factor: 2.867

9.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

Authors:  James F Morley; Heather R Brignull; Jill J Weyers; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

Review 10.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

View more
  188 in total

1.  Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.

Authors:  Monica Beam; M Catarina Silva; Richard I Morimoto
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

Review 3.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

Review 4.  Spatial protein quality control and the evolution of lineage-specific ageing.

Authors:  Thomas Nyström
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-12       Impact factor: 6.237

Review 5.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

6.  Stress and aging induce distinct polyQ protein aggregation states.

Authors:  Lorenza E Moronetti Mazzeo; Devin Dersh; Marco Boccitto; Robert G Kalb; Todd Lamitina
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

7.  Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection.

Authors:  Bashkim Kokona; Carrie A May; Nicole R Cunningham; Lynn Richmond; F Jay Garcia; Julia C Durante; Kathleen M Ulrich; Christine M Roberts; Christopher D Link; Walter F Stafford; Thomas M Laue; Robert Fairman
Journal:  Protein Sci       Date:  2015-12-21       Impact factor: 6.725

Review 8.  RNA interference technologies for understanding and treating neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 9.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Single-nucleotide variations in the genes encoding the mitochondrial Hsp60/Hsp10 chaperone system and their disease-causing potential.

Authors:  Peter Bross; Zhijie Li; Jakob Hansen; Jens Jacob Hansen; Marit Nyholm Nielsen; Thomas Juhl Corydon; Costa Georgopoulos; Debbie Ang; Jytte Banner Lundemose; Klary Niezen-Koning; Hans Eiberg; Huanming Yang; Steen Kølvraa; Lars Bolund; Niels Gregersen
Journal:  J Hum Genet       Date:  2006-10-27       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.